吸入激素联合噻托溴铵治疗哮喘-慢阻肺重叠综合症的临床效果

Abstract
Figure/Table
References (15)
Related Citation (11)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the therapeutic effect of inhaled corticosteroid combined with Tiotropium Bromide in the treatment of patients with asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome.Methods Sixty patients with asthma-COPD overlap syndrome who were admitted to our hospital from June 2017 to June 2018 were selected as the subjects.They were divided into the control group and the observation group by random number table method,with 30 cases in each group.In the control group,corticosteroid inhalation alone was used,while in the observation group,Tiotropium Bromide was added on the basis of corticosteroid inhalation.The pulmonary function,asthma control test (ACT) score,COPD assessment test (CAT) score,and the occurrence of complications after medication were compared between the two groups.Results There were no significant differences in the forced expiratory volume in one second (FEV1),residual volume/total lung capacity (RV/TLC),and inspiratory capacity/total lung capacity (IC/TLC),ACT score or CAT score between the two groups before the treatment (P>0.05).After treatment,the ratio of IC/TLC and FEV1 in the observation group were higher than those in the control group,and RV/TLC was lower compared with that in the control group,with statistical significance (P<0.05).The total incidence of palpitations,dry mouth,inhibited urination,and oral candida infection was lower than that of the control group after treatment (P<0.05).The ACT score of the observation group was higher than that of the control group,and CAT score was lower than that of the control group after treatment,and the differences were statistically significant (P<0.05).Conclusion The application of inhaled corticosteroid combined with Tiotropium Bromide in the treatment of patients with asthma-COPD overlap syndrome is better than inhaled corticosteroid therapy alone,and can reduce the incidence of complications and promote the recovery of lung function,and reduce the occurrence of asthma and COPD patients,which has high clinical value and is worthy of widespread promotion.

Key words： Asthma-Chronic obstructive pulmonary disease overlap syndrome Inhaled hormone therapy Tiotropium bromide

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XU Shuo

Cite this article:

XU Shuo. Clinical effect of inhaled corticosteroid combined with Tiotropium Bromide in the treatment of asthma-chronic obstructive pulmonary disease overlap syndrome[J]. 中国当代医药, 2019, 26(27): 70-72.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2019/V26/I27/70

[1]	张智娟.吸入激素联合噻托溴铵治疗哮喘-慢阻肺重叠综合症的临床疗效评价[J].中国现代医生，2017，55（19）：43-45.
[2]	王波.吸入激素联合噻托溴铵治疗哮喘-慢阻肺重叠综合症的临床疗效观察[J].当代医学，2017，23（3）：84-85.
[3]	吴孟烽，许曼，韦冬琴，等.糖皮质激素联合噻托溴铵治疗哮喘-慢阻肺重叠综合症的临床研究[J].内科，2016，11（6）：910-911.
[4]	郑燕冰.吸入激素联合噻托溴铵治疗哮喘-慢阻肺重叠综合征的临床效果[J].中国当代医药，2018，25（18）：42-44.
[5]	范宏军.糖皮质激素与噻托溴胺联合治疗哮喘-慢阻肺重叠综合症的疗效探讨[J].中国老年保健医学，2017，15（4）：61-62.
[6]	崔丽平，陈希胜，李旭.布地奈德粉吸入剂联合噻托溴铵粉雾剂治疗哮喘-慢阻肺重叠综合症的临床疗效[J].实用心脑肺血管病杂志，2017，25（3）：100-103.
[7]	褚岩.肺功能测定鉴别支气管哮喘、慢阻肺及哮喘慢阻肺重叠综合征的临床价值分析[J].中国现代医生，2018，56（3）：38-40.
[8]	廉志宏，乌日汗.噻托溴铵联合沙美特罗/氟替卡松治疗哮喘-慢阻肺重叠综合征的临床效果分析[J].中国实用医药，2018，13（32）：105-106.
[9]	范宏军.糖皮质激素与噻托溴胺联合治疗哮喘-慢阻肺重叠综合征的疗效探讨[J].中国老年保健医学，2017，15（4）：61-62.
[10]	褚岩.肺功能测定鉴别支气管哮喘、慢阻肺及哮喘慢阻肺重叠综合征的临床价值分析[J].中国现代医生，2018，56（3）：38-40.
[11]	王雅宁，李宝明.吸入型糖皮质激素联合噻托溴铵治疗ACOS 临床多点观察[J].当代医学，2017，23（12）：103-104.
[12]	陈健红.探讨吸入激素联合噻托溴铵治疗哮喘-慢阻肺重叠综合征临床效果[J].系统医学，2018，3（18）：19-21.
[13]	付云杰.多索茶碱与噻托溴铵粉联合治疗慢阻肺对肺功能的影响[J].中国现代医生，2019，57（8）：44-45.
[14]	李彦芳，李震.孟鲁司特钠治疗哮喘-慢阻肺重叠综合征的临床效果分析[J].内蒙古医学杂志，2018，50（11）：71-72.
[15]	刘雪琴，关晓暄，孙立军.噻托溴铵联合沙美特罗/氟替卡松治疗哮喘-慢阻肺重叠综合征的临床评价[J].临床肺科杂志，2017，22（3）：513-516.